FDA issued a Warning Letter to Jazz Pharmaceuticals, Inc on 10/11/2011 for a previous inspection.
483 Jazz Pharmaceuticals May 2012

483 Jazz Pharmaceuticals May 2012

Peter Baker FDA, Jennifer Johnson FDA$119.00 - Available Now

FDA investigators audited the Jazz Pharmaceuticals - Palo Alto, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 30 May 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 30 May 2012
  • Location: Palo Alto, United States
  • FEI: 3005615655
Add To Cart